Skip to main content
. Author manuscript; available in PMC: 2013 Jun 25.
Published in final edited form as: Pediatr Infect Dis J. 2012 Sep;31(9):e152–e157. doi: 10.1097/INF.0b013e3182638012

TABLE 1.

Studies defining treatment failure in severe or very severe pneumonia.

Reference Study population N Clinical Definition of Treatment Failure Failure
Shann et al.
1985(29)
Ages not stated; Papua New Guinea; Inpatients; Severe pneumonia 748 At any point: Change of antibiotic treatment; Death 15.9%
Strauss et al.
1998(30)
2–59 months; Pakistan; Outpatient and inpatient; Non-severe and severe pneumonia 595 At 48 hours, any of: Resting SaO2 ≤ 87%; tachypnoea; any danger sign; No improvement or deterioration in the opinion of a senior clinician 20.5%
Duke et al.
2002(31)
1-59 months; Papua New Guinea; Inpatient; Very severe pneumonia 1116 At 5 days, any 4 of: Fever, Tachypnoea/apnoeas, chest wall indrawing, crepitations, bronchial breathing, low oxygen sats; Death ; Readmission within 1 month 18.6%
Addo-Yobo et
al. 2004(14)
3–59 month; International; Inpatient; Severe pneumonia 1702 At 48 hours, any 1 of: Danger signs, low SaO2, persistent indrawing, serious adverse drug reaction, new antibiotic, new comorbidity, abscondment, death 19%
McNally et al.
2007(5)
1-59 months; South Africa; Inpatient; Severe and very severe pneumonia 358 At 48 hours, persistence or worsening of any 1 of: heart rate, respiratory rate, temperature, inability to drink, increased oxygen requirements; New danger signs; Absconded; Change of antibiotic for new disease or blood culture result; Death 35%
Asghar et al.
2008 (12)
(SPEAR study)
2-59 months; International; Inpatient; Very severe pneumonia 958 At day 5, persistent or new: Inability to drink, tachypnoea, reduced conscious level, meningitis, empyema, renal failure, septic shock; Serious adverse drug reaction; Change of antibiotic treatment; Abscondment; Death 13.5%
Hazir et al
2008(15)
3-59 months; Inpatient versus outpatient; Severe pneumonia 2037 At day 3: Clinical deterioration; Persistence of fever with lower chest indrawing; Hospitalisation of outpatient; Development of comorbid condition requiring antibiotic; Abscondment; Death 8%
Addo Yobo et
al. 2011(32)
2-59 months, multi-national; Severe pneumonia 823 At 72 hours, persistence of fever and lower chest indrawing. Or, at day 6, clinical deterioration; Inability to take oral medication because of persisting vomiting; serious adverse event related to amoxicillin; developing a co-morbid condition; either fever or lower chest indrawing; new chest indrawing or fast breathing 9.2%